Rajesh Keshvara

Rajesh Keshvara

Auto-generated profile, based on publicly available information

Rajesh Keshvara

Foothills Medical Centre, Calgary, AB, Canada (R.K.).

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2024 in JACC: Cardiovascular Interventions
Verified
Journal Article
Open access
EFEduardo Flores-Umanzor
Eduardo Flores-Umanzor
BABandar Alshehri
Bandar Alshehri
RKRajesh Keshvara
Rajesh Keshvara
WWWilliam Wilson
William Wilson
MOMark Osten
Mark Osten
EHEric Horlick
Eric Horlick
Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease. Palliative procedures, either surgical or transcatheter, aim to improve oxygen saturation, affording definitive procedures at a later stage. Transcatheter interventions have been used before and after surgical palliative or definitive repair in children and adults. This review aims to provide an overview of the different catheter-based interventions for TOF across all age groups, with an emphasis on palliative interventions, such as patent arterial duct stenting, right ventricular outflow tract stenting, or balloon pulmonary valvuloplasty in infants and children and transcatheter pulmonary valve replacement in adults with repaired TOF, including the available options for a large, dilated native right ventricular outflow tract.

1 December 2024 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
EFEduardo Flores-Umanzor
Eduardo Flores-Umanzor
RLRaquel Luna-López
Raquel Luna-López
PCPedro Luis Cepas-Guillen
Pedro Luis Cepas-Guillen
SMSílvia Montserrat
Sílvia Montserrat
BABandar Alshehri
Bandar Alshehri
EHEric Horlick
Eric Horlick
The Fontan circuit is associated with chronically elevated systemic venous pressures and decreased cardiac output, often leading to circuit failure. Managing Fontan circuit failure is complex and requires multiple therapeutic options. Transcatheter interventions have emerged as a reliable approach. They can alleviate obstructions and improve cyanosis by enhancing pulmonary blood flow and oxygen saturation. These procedures can also increase cardiac output and reduce systemic venous pressure, contributing to patient stabilization. In addition, they help mitigate volume overload and decrease the risk of bleeding during heart or combined heart and liver transplants. In recent years, percutaneous interventions have rapidly evolved and become a key therapeutic option for addressing various aspects of Fontan circuit failure. These interventions should be considered integral to the management strategy for this specific patient population.